| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/17/2004 | CA2254658C New naphtalene compounds, their method of preparation and pharmaceutical compositions containing these compounds |
| 08/17/2004 | CA2241611C Chronic, bolus administration of d-threo methylphenidate |
| 08/17/2004 | CA2236582C Substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives |
| 08/17/2004 | CA2155673C N-alkyl-2-substituted atp analogues |
| 08/17/2004 | CA2139790C Tablets with thioctic acid of specific grain size |
| 08/17/2004 | CA2133177C Rapamycin formulations for oral administration |
| 08/17/2004 | CA2133175C Rapamycin formulations for oral administration |
| 08/17/2004 | CA2130375C Insecticide and insect repellant compositions |
| 08/17/2004 | CA2122908C Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones |
| 08/17/2004 | CA2087679C The process for transport of agents across the skin and compositions and articles useful therein |
| 08/14/2004 | CA2457465A1 Method for reducing the glycemic index of food |
| 08/13/2004 | WO2004072084A1 Salt of benzosulfonic acid containing clopidogrel and use thereof for the production of pharmaceutical formulations |
| 08/13/2004 | CA2468089A1 Salt of benzenesulfonic acid with clopidogrel and its use for producing pharmaceutical formulations |
| 08/12/2004 | WO2004067704A2 Freeze-dried fibrin matrices and methods for preparation thereof |
| 08/12/2004 | WO2004067553A2 Tolerance-induced targeted antibody production |
| 08/12/2004 | WO2004067550A2 Novel use of mifepristone and derivatives thereof as hedgehog protein signalling pathway modulators and applications of same |
| 08/12/2004 | WO2004067544A1 Caprazene as novel compound and derivatives thereof, and caprazol as novel compound and derivatives thereof |
| 08/12/2004 | WO2004067542A1 Oligosaccharide derivative |
| 08/12/2004 | WO2004067537A1 Triazole derivatives and antifungal agents containing the same |
| 08/12/2004 | WO2004067535A1 Thienopyrimidine compounds and use thereof |
| 08/12/2004 | WO2004067526A1 CRYSTAL OF (23S)-1α-HYDROXY-27-NOR-25-METHYLENEVITAMIN D3-26,23-LACTONE AND PROCESS FOR PRODUCING THE SAME |
| 08/12/2004 | WO2004067522A1 Azaphenylalanine derivatives and their use as antithrombotic agents |
| 08/12/2004 | WO2004067521A1 Thiazole derivatives and their use as vap-1 inhibitors |
| 08/12/2004 | WO2004067516A1 2,4-diaminopyrimidine derivatives useful as inhibitors of pkc-theta |
| 08/12/2004 | WO2004067508A2 Use of photodynamic therapy therapeutic agents entrapped in ceramic nanoparticles |
| 08/12/2004 | WO2004067506A2 Substituted heterocyclic compounds |
| 08/12/2004 | WO2004067505A2 Bismuth dithiocarbamate compounds and uses thereof |
| 08/12/2004 | WO2004067504A1 2-substituted vitamin d derivative |
| 08/12/2004 | WO2004067498A2 Aryl alkyl carbamate derivatives production and use thereof in therapy |
| 08/12/2004 | WO2004067496A1 Crystalline form of nateglinide |
| 08/12/2004 | WO2004067495A1 Alanines compounds, method of preparing them and their use |
| 08/12/2004 | WO2004067482A2 Substituted anilide ligands for the thyroid receptor |
| 08/12/2004 | WO2004067481A2 Improved jasmine aromachemicals |
| 08/12/2004 | WO2004067480A2 Substituted phenylurea derivatives as hdac inhibitors |
| 08/12/2004 | WO2004067093A2 Nk1 receptor antagonists for the treatment of functional dyspepsia |
| 08/12/2004 | WO2004067063A2 Improved formulations for transmucosal vaginal delivery of bisphosphonates |
| 08/12/2004 | WO2004067039A1 Multiparticulate compositions of milnacipran for oral administration |
| 08/12/2004 | WO2004067037A1 Intestinal environment controlling agent for oral use and normal intestinal flora growing kit for oral use |
| 08/12/2004 | WO2004067036A1 Devices and compositions containing boron and silicon for use in neutron capture therapy |
| 08/12/2004 | WO2004067027A2 Osteogenic composition |
| 08/12/2004 | WO2004067022A2 Use of a mixture containing neuropeptides and steroids for treating disturbances of psychosocial experiences and behaviour |
| 08/12/2004 | WO2004067017A1 Feng-you-jing spray |
| 08/12/2004 | WO2004067014A1 Solid preparation for dialysis and process for producing the same |
| 08/12/2004 | WO2004067013A1 Compositions and methods for restoring bacterial flora |
| 08/12/2004 | WO2004067012A1 Limposomes containing asiaticoside and the uses thereof |
| 08/12/2004 | WO2004067011A1 Amelioration of decreased weight and growth by n-acylated glucosamines |
| 08/12/2004 | WO2004067010A1 Use of 3-methoxy-pregnenolone in the production of a medicament for treating neurodegenerative diseases |
| 08/12/2004 | WO2004067009A1 Pharmaceutical composition comprising an extract or compounds isolated from elfvingia applanata for the prevention and the treatment of diabetes and diabetic complications |
| 08/12/2004 | WO2004067008A1 Receptor agonists |
| 08/12/2004 | WO2004067007A1 NEW CRYSTALLINE MODIFICATION OF 2-(3,5-BIS-TRIFLUOROMETHYL-PHENYL)-N-[6-(1,1-DIOXO-1λ6-THIOMORPHOLIN-4-YL)-4(4-FLUORO-2-METHYL-PHENYL)-PYRIDIN-3-YL]-N-METHYL-ISOBUTYRAMIDE |
| 08/12/2004 | WO2004067006A1 Combination of a pde iv inhibitor and a tnf-alpha antagonist |
| 08/12/2004 | WO2004067005A1 Liquid pharmaceutical formulations of palonosetron |
| 08/12/2004 | WO2004067004A1 A rapid-acting pharmaceutical composition |
| 08/12/2004 | WO2004067003A1 Medicine for prevention of and treatment for arteriosclerosis and hypertension |
| 08/12/2004 | WO2004067002A2 SELECTIVE mGlu5 ANTAGONISTS FOR TREATMENT OF NEUROMUSCULAR DYSFUNCTION OF THE LOWER URINARY TRACT |
| 08/12/2004 | WO2004067001A1 Process for producing coated preparation |
| 08/12/2004 | WO2004067000A1 Benzthiazole-3 oxides useful for the treatment of proliferative disorders |
| 08/12/2004 | WO2004066999A1 Compositions containing 2, 2’ -methylenebisbenzimidazole derivatives for treating ischemia-related neuronal damage |
| 08/12/2004 | WO2004066998A1 Stable solid medicinal composition for oral administration |
| 08/12/2004 | WO2004066995A1 Method for treating ischemic stroke with melatonin |
| 08/12/2004 | WO2004066993A1 Use of 10-aminoaliphatyl-dibenz[b,f]oxepines for the treatment of degenerative ocular disorders |
| 08/12/2004 | WO2004066992A1 Medicinal composition for treating infection with drug-resistant staphylococcus aureus |
| 08/12/2004 | WO2004066991A1 Enteric sustained-release fine particles for tamsulosin or its salt and process for producing the same |
| 08/12/2004 | WO2004066990A2 Methods of treating lower urinary tract disorders using sodium channel modulators |
| 08/12/2004 | WO2004066989A1 Down-regulation of target-gene with pei/single-stranded oligoribonucleotide comp lexes |
| 08/12/2004 | WO2004066988A1 Fatigue reducing agent |
| 08/12/2004 | WO2004066987A2 Use of sodium channel modulators for treating gastrointestinal tract disorders |
| 08/12/2004 | WO2004066983A2 Controlled release of highly soluble agents |
| 08/12/2004 | WO2004066982A1 Stable oral benzimidazole compositions and processes for their preparation |
| 08/12/2004 | WO2004066981A1 Oral controlled release pharmaceutical composition containing metaxalone as active agent |
| 08/12/2004 | WO2004066980A2 Sustained release device and method for ocular delivery of carbonic anhydrase inhibitors |
| 08/12/2004 | WO2004066979A2 Sustained release device and method for ocular delivery of adrenergic agents |
| 08/12/2004 | WO2004066978A1 Powder pharmaceutical compositions |
| 08/12/2004 | WO2004066977A1 Solid agent for dialysis and process for producing the same |
| 08/12/2004 | WO2004066967A2 Method and kit for reducing the symptoms of peripheral vascular disease |
| 08/12/2004 | WO2004066963A2 N-cyclohexylaminocarbonyl benzenesulfonamide derivatives |
| 08/12/2004 | WO2004066962A2 Method of treatment of prostate cancer and composition for treatment thereof |
| 08/12/2004 | WO2004066960A2 Combination of h1, h3 and h4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis |
| 08/12/2004 | WO2004066956A2 Uses of integrin alphavbeta3 antagonists |
| 08/12/2004 | WO2004066955A2 Slowly digestible starch |
| 08/12/2004 | WO2004066954A2 A therapeutic composition for the treatment of hiv-1 and hiv-2 |
| 08/12/2004 | WO2004066952A2 Benzoxazole, benzothiazole, and benzimidazole derivatives for the treatment of cancer and other diseases |
| 08/12/2004 | WO2004066951A2 Quinoline derivatives as nk-2 and nk-3 receptor antagonists |
| 08/12/2004 | WO2004066943A2 Methods for diagnosis anf monitoring of neurological disease by detection of an encephalotoxin |
| 08/12/2004 | WO2004066940A2 Compositions and methods containing substituted quinolines and substituted diphenylsulfones |
| 08/12/2004 | WO2004066936A2 Method and assembly for liquid nitrogen therapy |
| 08/12/2004 | WO2004066935A2 Sensitive proteasome sensor constructs and methods for their design and use |
| 08/12/2004 | WO2004066934A2 Spermicidal and/or antifungal composition and methods of using the same |
| 08/12/2004 | WO2004066932A2 Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents |
| 08/12/2004 | WO2004066931A2 Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents |
| 08/12/2004 | WO2004066930A2 Method for inducing pain relief using imidazo[1,2-a]pyridine derivatives |
| 08/12/2004 | WO2004066929A2 Cycloalkyl containing anilide ligands for the thyroid receptor |
| 08/12/2004 | WO2004066924A2 Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid |
| 08/12/2004 | WO2004066923A2 Compositions and methods for improving recovery after general anesthesia |
| 08/12/2004 | WO2004066922A2 A method of treating breast cancer with androgen receptor antagonists |
| 08/12/2004 | WO2004066920A2 17-carbamoyloxy cortisol derivatives as selective glucocorticoid receptor modulators |
| 08/12/2004 | WO2004066913A2 Solid mosapride preparation |
| 08/12/2004 | WO2004066912A2 Anti-inflammatory compositions and uses thereof |
| 08/12/2004 | WO2004066753A1 Milk product in dry form comprising unesterified sterol |
| 08/12/2004 | WO2004066732A1 Desinfecting nitrous acid compositions and process for using the same |